Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 27:11:1578.
doi: 10.12688/f1000research.126091.5. eCollection 2022.

Expression of Fascin and SALL4 in odontogenic cysts and tumors: an immunohistochemical appraisal

Affiliations

Expression of Fascin and SALL4 in odontogenic cysts and tumors: an immunohistochemical appraisal

Spoorti Kulkarni et al. F1000Res. .

Abstract

Background: Various stemness markers (SOX2, OCT4, and NANOG) have been studied in odontogenic cysts and tumors. However, studies on SALL4 having similar properties of stemness has not been documented. Additionally, insight into fascin as a migratory molecule is less explored. In this study, the expression of SALL4 and fascin were evaluated in ameloblastoma, adenomatoid odontogenic tumor (AOT), odontogenic keratocyst (OKC), dentigerous cyst (DC), radicular cyst (RC), and calcifying odontogenic cyst (COC).

Methods: Semi-quantitative analysis of fascin and SALL4 immuno-positive cells was done in a total of 40 cases of ameloblastoma (11 plexiform, 12 follicular, 12 unicystic, and 5 desmoplastic) variants, 6 cases of AOT, 15 each of OKC, DC, RC and 5 of COC. Chi-square test was applied to evaluate the association between SALL4 and fascin expression in odontogenic cysts and tumors.

Results: Fascin immunopositivity was observed in peripheral ameloblast-like cells, and the expression was weak or absent in stellate reticulum-like cells. A moderate to weak immune-reactivity to SALL4 was observed in the cytoplasm of ameloblastoma, epithelial cells of dentigerous and radicular cysts, having a marked inflammatory infiltrate, which was an interesting observation. COC and AOT had negative to weak expressions. No recurrence has been reported.

Conclusions: Expression of fascin in ameloblastomas elucidate their role in motility and localized invasion. Its expression in less aggressive lesions like DC, COC, AOT will incite to explore the other functional properties of fascin. SALL4 expression in the cytoplasm of odontogenic cysts and tumors may represent inactive or mutant forms which requires further validation.

Keywords: Ameloblastoma; Fascin; Immunohistochemistry; Odontogenic cysts; Odontogenic tumors; SALL4.

PubMed Disclaimer

Conflict of interest statement

No competing interests were disclosed.

Figures

Figure 1.
Figure 1.. Expression of fascin in odontogenic tumors & cysts.
Histopathological variants of ameloblastoma: (A) Follicular (IHC, 10×), (B) Plexiform (IHC, 10×), (C) Unicystic (IHC, 10×), (D) Desmoplastic (IHC, 4×), (E) Focal immune-positivity for fascin in AOT (IHC, 10×), (F) COC (IHC, 10×), (G) OKC (IHC, 4×), (H) Dentigerous cyst (IHC, 10×), (I) Radicular cyst, (IHC, 10×), (J) Immuno-positivity for fascin in basal cells of the oral epithelium (IHC, 4×), (K) Oral squamous cell carcinoma used as positive control stained with fascin (IHC, 10×). IHC-Immunohistochemistry. The software used record images is Olympus-DP2BSW (ver 2.1).
Figure 2.
Figure 2.. Expression of SALL4 in odontogenic cysts & tumors.
Variants of ameloblastoma (A) Follicular (IHC, 10×, Inset; IHC 40×), (B) Combination of follicular & plexiform (IHC,10×), (C) Unicystic (IHC, 4×), D) Immuno-negative in AOT (IHC, 10×), (E) OKC (IHC, 20×), (F) Dentigerous cyst (IHC, 10×), (G) Radicular cyst (IHC, 20×), (H) Immuno-negative COC (IHC, 10×), (I) Epithelial cells & ectomesenchyme surrounding the bud stage (IHC, 10×), (J) Bell stage: Focal positive to SALL4 in inner enamel epithelium (IEE) and sporadic expression in dental papilla (DP) (IHC, 10×), (K) Strong expression of SALL4 in dysgerminoma (positive control 20×). IHC-Immunohistochemistry.

Similar articles

References

    1. Effiom OA, Ogundana OM, Akinshipo AO, et al. : Ameloblastoma: current etiopathological concepts and management. Oral Dis. 2018;24:307–316. 10.1111/odi.12646 - DOI - PubMed
    1. Reichart P, Sciubba JJ, Philipsen HP: Splitters or lumpers: The 2017 WHO Classification of Head and Neck Tumors. J. Am. Dent. Assoc. 2018;149:567–571. 10.1016/j.adaj.2018.03.029 - DOI - PubMed
    1. Ahire MS, Tupkari JV, Chettiankandy TJ, et al. : Odontogenic tumors: A 35-year retrospective study of 250 cases in an Indian (Maharashtra) teaching institute. Indian journal of cancer. 2018 Jul 1;55(3):265–272. 10.4103/ijc.IJC_145_18 - DOI - PubMed
    1. Pandiar D, Shameena PM, Sudha S, et al. : Odontogenic Tumors: A 13-year Retrospective Study of 395 Cases in a South Indian Teaching Institute of Kerala. Oral & Maxillofacial Pathology Journal. 2015 Jul 1;6(2).
    1. Hendra FN, Van Cann EM, Helder MN, et al. : Global incidence and profile of ameloblastoma: a systematic review and meta-analysis. Oral Diseases. 2020 Jan;26(1):12–21. 10.1111/odi.13031 - DOI - PubMed